Premium
Global alternative asset manager The Carlyle Group’s Asia Growth Fund is selling its majority stake in a medical technology...
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.







